Strategic Growth Target orthopedic and dental implant manufacturers and distributors looking to reduce implant instability, leveraging OsteoCentric’s UnifiMI technology and MIS Bone Preservation capabilities for joint ventures, licensing deals, or co-development agreements.

Market Expansion Position as a disruptive interface technology enabling primary implant stability over time, appealing to hospitals, clinics, and surgical centers seeking improved outcomes and reduced revision rates in orthopedics, spine, and dental segments.

Clinical Advantage Highlight clinically proven advantages of Instant Interlocking Thread-form and MI approach to drive conversations with procurement and clinical decision-makers about value proposition, patient outcomes, and long-term cost savings.

Strategic Partnerships Leverage recent funding and executive hires to pursue partnerships with large medtech players or distribution networks for rapid adoption, co-marketing, and scalable manufacturing of UnifiMI-enabled implants.

Awareness & Outreach Capitalize on press coverage and industry events to generate leads among surgeons, materials engineers, and R&D teams, offering trials, pilot programs, and educational demonstrations that showcase primary stability over time.